New hope for brain cancer: experimental combo targets glioblastoma
Disease control
Ongoing
This study tests whether adding an experimental drug called BPM31510 (with vitamin K1) to standard radiation and chemotherapy can help people with newly diagnosed glioblastoma, an aggressive brain cancer. About 50 adults will receive the combination, and researchers will track ho…
Phase: PHASE2 • Sponsor: BPGbio • Aim: Disease control
Last updated May 14, 2026 12:02 UTC